Source: BioPortfolio

OrSense: OrSense obtains FDA clearance to commercialize NBM200 System in US

OrSense is a medical device company that develops and markets noninvasive hemoglobin pulse and oximetry measurement systems based on its innovative Occlusion Spectroscopy technology. The OrSense NBM200 device The post OrSense obtains FDA clearance to comme...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
CEO Avatar

CEO

Yoav Reisman

CEO Approval Rating

85/100

Read more